4D Path

    OverviewSuggest Edit

    4D Path is a company specializing in morphological and genetic testing. It aims to integrate cancer diagnostics and precision medicine into a digital platform based on a single hematoxylin and eosin (H&E) stained whole slide biopsy image. The technology predicts four classes of breast cancer with respect to the receptor (ER, PR) and protein (HER2) overexpression status, as well as the BRAF/NRAS mutation status of malignant melanomas.
    TypePrivate
    Founded2016
    Website4dpath.com

    Latest Updates

    Employees (est.) (May 2020)4
    Cybersecurity ratingAMore
    Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
    Banner background

    4D Path Financials and Metrics

    Summary Metrics

    Founding Date

    2016

    4D Path Cybersecurity Score

    Cybersecurity ratingPremium dataset

    A

    98/100

    SecurityScorecard logo

    4D Path Online and Social Media Presence

    Embed Graph

    4D Path News and Updates

    Dr. Craig Bunnell Joins Advisory Board of Cancer Diagnostic and Precision Oncology Platform Developer 4D Path

    NEWTON, Mass., Aug. 24, 2021 (GLOBE NEWSWIRE) -- 4D Path, creator of a patented computer-aided pan-cancer diagnostic and precision oncology platform, is pleased to announce that Dr. Craig A. Bunnell, MD, MPH, MBA, has joined the company’s distinguished advisory board. A widely recognized authority…

    4D Path, University of Leeds Extend Contract to Collaboratively Validate New Technology to Help Doctors More Accurately Diagnose Breast Cancer

    NEWTON, Mass., March 16, 2021 (GLOBE NEWSWIRE) -- 4D Path, creator of a patented computer-aided cancer diagnostic and precision oncology platform, has extended its existing partnership with the University of Leeds in the UK through 2027, the two organizations announced today. Through a prior three…

    FDA Grants Breakthrough Designation to 4D Path for Novel Cancer Diagnostic Solution

    Potential for a New Standard of Care to Improve Diagnostic Accuracy for Breast Cancer Exclusively from H&E Biopsy/Resection Images Potential for a New Standard of Care to Improve Diagnostic Accuracy for Breast Cancer Exclusively from H&E Biopsy/Resection Images

    4D Path Frequently Asked Questions

    • When was 4D Path founded?

      4D Path was founded in 2016.

    • How many employees does 4D Path have?

      4D Path has 4 employees.

    • Who are 4D Path competitors?

      Competitors of 4D Path include HalioDx, Genoptix and EXACT Sciences.